Delta Financial Group Inc. Reduces Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Delta Financial Group Inc. trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 25.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 5,670 shares of the company’s stock after selling 1,980 shares during the period. Delta Financial Group Inc.’s holdings in GE HealthCare Technologies were worth $443,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Cherry Creek Investment Advisors Inc. increased its position in shares of GE HealthCare Technologies by 0.3% during the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock valued at $2,920,000 after purchasing an additional 114 shares during the last quarter. Independence Bank of Kentucky grew its position in GE HealthCare Technologies by 6.0% during the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock valued at $158,000 after buying an additional 114 shares during the period. Tandem Capital Management Corp ADV grew its position in GE HealthCare Technologies by 0.4% during the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock valued at $2,205,000 after buying an additional 118 shares during the period. Arcus Capital Partners LLC increased its holdings in GE HealthCare Technologies by 3.0% during the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company’s stock valued at $322,000 after buying an additional 119 shares during the last quarter. Finally, Custom Index Systems LLC raised its position in GE HealthCare Technologies by 4.4% in the fourth quarter. Custom Index Systems LLC now owns 2,843 shares of the company’s stock worth $222,000 after acquiring an additional 120 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

GEHC has been the subject of a number of recent research reports. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Stock Down 1.1 %

Shares of GEHC opened at $91.09 on Monday. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $41.66 billion, a PE ratio of 21.04, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The business’s 50 day moving average is $85.05 and its 200 day moving average is $85.90.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.